Acute Erythroblastic Leukemia is a rare form of acute myeloid leukemia in which the myeloproliferation is the erythroblastic precursors. In the blood and bone marrow, a large amount of immature blood cells are produced and,in advance forms, can make up over 50% of the cells in the blood and marrow causing oxygen to be unable to be delivered throughout the body. Lack of oxygen, otherwise known as anemia, causes patients to feel weak and fatigued. Red blood cells are not the only cells affected in Acute Erythroblastic Leukemia; patients also have very low white blood cells and platelet numbers. This form of leukemia is a very aggressive form and is not easily treated with common types of therapy.
Acute Erythroblastic Leukemia Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Acute Erythroblastic Leukemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 2379 products for the study of Acute Erythroblastic Leukemia that can be applied to Western Blot, Flow Cytometry, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.